We have some exciting news to share! The Motley Fool UK has now become The Twelfth Magpie -- an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. This site is our new home, and there will be extra tweaks made across the coming few days as we settle in. So if anything looks a little off, please bear with us!

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Should you pile into IQE plc, down 15% today?

Is IQE plc (LON: IQE)’s plummeting share price signalling an opportunity or a warning?

| More on:

You’re reading a free article with opinions that may differ from The Twelfth Magpie’s Premium Investing Services. Become a member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more, and get a free 'Best Buy Now' stock!.

Investors in IQE (LSE: IQE) have enjoyed a great run, from below 17p per share in July 2016 to a little over 175p per share in November 2017, that’s a rise of around 930%. However, today’s share price is down – to 105p, as I write – representing a fall of 40% or so from November’s peak – ouch!

If you missed the first wave of excitement, is this dip a second chance to pile in for the next climb as the firm’s growth potential plays out? I’m interested, but cautious, and here’s why…

Should you buy Iqe Plc shares today?

Before you decide, please take a moment to review this report first. Despite ongoing uncertainties from US tariffs to global conflicts, Mark Rogers and his team believe many UK shares still trade at substantial discounts, offering savvy investors plenty of potential opportunities to learn about.

That’s why this could be an ideal time to secure this valuable research – Mark’s analysts have scoured the markets to reveal 5 of his favourite long-term ‘Buys’. Please, don’t make any big decisions before seeing them.

A compelling tale

IQE’s story is a good one. The firm earns its living by manufacturing advanced wafers for the semiconductor industry. By reading company statements, it becomes clear that the directors believe it enjoys a well-protected niche in the industry and is able to defend it with accumulated expertise and intellectual property.

In November, the firm raised £95m in a placing, at a price of 140p per share, in order to ramp up capital expenditure aimed at scaling the business for “multiple high growth mass-market opportunities.”  

The directors see Vertical Cavity Surface Emitting Laser’s (VCSEL) – a key component in fibre optic communications devices – as being a long-term growth driver for IQE across a range of applications such as sensing, Light Detection and Ranging (LDAR), optical communications, machine vision and heat assisted magnetic recording.

In December, chief executive Dr Drew Nelson said: “The adoption of VCSELs in the mass market has been a key revenue driver in the year.” Indeed, the firm is the only supplier of epitaxial wafers to Apple for the consumer technology giant’s TrueDepth 3D camera, which could lead to rapid growth in revenues and profits generated from both Apple and its competitors, if they take up IQE’s offering. If we do end up seeing the acceleration of IQE’s products in mass-market smartphones and other applications, we could witness profits multiplying many times down the road.

An interesting valuation now

It seems clear that the stock rose in anticipation of this positive forward vision, but the reversal we are seeing now suggests speculation pushed the share price ahead of events. Perhaps we’ve just seen a bubble in the price. Today’s 105p is far more realistic.

At this level, the historic price-to-earnings rating is 32. Meanwhile, City analysts following the firm – who seem equally as excited by the firm’s forward prospects – expect earnings to grow by 29% during 2018, and by 44% in 2019, which suggests acceleration that may, or may not, continue.

I think the valuation is now interesting. But we’re dealing with a very popular stock here, and I reckon it’s important to take account of sentiment and psychology as well as fundamentals when making buying and selling decisions.

For me, it makes no sense to buy a stock that is still falling, so I’d want to see some kind of base form on the chart and evidence that the share-price trend has reversed, such as two or three higher lows and higher highs on the chart. Remember, prices can move much further than we believe possible in either direction, and this is just the type of stock where that effect is likely to be most evident.

Kevin Godbold has no position in in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Investing Articles

Forget Rolls-Royce shares, this incredible penny stock is forecast to soar 762%!

Faron Pharmaceuticals shares are forecast to gain 762% in the coming 12 months, mimicking the recent performance of Rolls-Royce shares.

Read more »

Close-up of children holding a planet at the beach
Investing Articles

How to turn a £20,000 ISA into a £20-a-day passive income stream

Does earning regular passive income seem out of your grasp? Break it down to a simple, step-by-step plan, and it’s…

Read more »

UK financial background: share prices and stock graph overlaid on an image of the Union Jack
Investing Articles

3 UK shares tipped to soar 100% (or more) in the next 12 months

Mark Hartley assesses the growth potential of three lesser-known UK shares with optimistic broker targets. Could they double in value…

Read more »

Curtains, happy woman and thinking of future in home, planning and reflection of mindset with view. Window, smile and African girl with vision, ideas and dream for morning inspiration in living room.
Investing Articles

Up 36% in 3 months! Is this beaten-down FTSE 100 growth stock finally ready to rocket?

Sensing a bargain, Harvey Jones snapped up this growth stock whose shares have fallen by half. Suddenly things are starting…

Read more »

Image of happy young people man and woman in basic clothing thinking and touching chin while looking aside isolated over yellow background
Investing Articles

Up 147% with a 6%+ yield and dirt-cheap P/E – yet this FTSE 100 dividend stock still flies under the radar

Harvey Jones flags up an impressive UK-listed dividend stock that may have passed some investors by. What's driving its stellar…

Read more »

Mining truck in a coal open pit mine
Investing Articles

Forget SpaceX! 2 top growth stocks to consider buying in August

Hunting for growth stocks to buy? Ben McPoland spotlights a tech share from across the pond and another in the…

Read more »

Investing Articles

£1,500 buys 447 shares in this UK stock that’s trouncing the FTSE 100

The FTSE 100's up nicely in the past year, but my favourite growth stock from the FTSE 250 has blown…

Read more »

Electric cars charging at a charging station
Investing Articles

Is this $7 stock the next Tesla?

After skyrocketing over the past decade-and-a-half, everyone has heard of Tesla stock. But this $7 upstart is still under the…

Read more »